NEO - NeoGenomics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NEO is currently covered by 13 analysts with an average price target of $12.97. This is a potential upside of $5.27 (68.44%) from yesterday's end of day stock price of $7.7.

NeoGenomics's activity chart (see below) currently has 132 price targets and 133 ratings on display. The stock rating distribution of NEO is 90.7% BUY and 9.3% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.41% with an average time for these price targets to be met of 112.28 days.

Highest price target for NEO is $19, Lowest price target is $15, average price target is $19.22.

Most recent stock forecast was given by MATTHEW SYKES from GOLDMAN SACHS on 17-Apr-2025. First documented stock forecast 03-Oct-2016.

Currently out of the existing stock ratings of NEO, 39 are a BUY (90.7%), 4 are a HOLD (9.3%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$4.73 (46.06%)

$18

16 days ago
(17-Apr-2025)

3/7 (42.86%)

$5.45 (57.07%)

174

Buy

$18

$7.73 (75.27%)

$20

2 months 7 days ago
(26-Feb-2025)

4/7 (57.14%)

$7.12 (65.44%)

188

Buy

$19

$8.73 (85.00%)

$19

3 months 18 days ago
(15-Jan-2025)

3/20 (15%)

$4.29 (29.16%)

191

Hold

$18

3 months 20 days ago
(13-Jan-2025)

10/12 (83.33%)

$2.2 (13.92%)

134

Hold

$19

$8.73 (85.00%)

$17

4 months 20 days ago
(13-Dec-2024)

1/2 (50%)

$1.27 (7.16%)

28

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NEO (NeoGenomics) average time for price targets to be met?

On average it took 112.28 days on average for the stock forecasts to be realized with a an average price target met ratio 57.41

Which analyst has the current highest performing score on NEO (NeoGenomics) with a proven track record?

ALEXANDER NOWAK

Which analyst has the most public recommendations on NEO (NeoGenomics)?

Alexander Nowak works at CRAIG HALLUM and has 22 price targets and 7 ratings on NEO

Which analyst is the currently most bullish on NEO (NeoGenomics)?

Sandy Draper with highest potential upside - $43.74

Which analyst is the currently most reserved on NEO (NeoGenomics)?

Bryan Brokmeier with lowest potential downside - -$1.3

NeoGenomics in the News

NeoGenomics price target lowered to $10 from $17 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on NeoGenomics (NEO) to $10 from $17 and keeps an Equal Weight rating on the shares. The company’s Q1 miss was primarily driven by lower non-clinical revenue and lower than expected average unit price, says the analyst, who sees “more questions than answers” following the company’s quarterly report....

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

FORT MYERS, Fla., April 08, 2025–(BUSINESS WIRE)–NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its first quarter 2025 financial results prior to the open of the U.S. financial markets on Tuesday, April 29, 2025. Company management will host a webcast and conference...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?